• LAST PRICE
    261.1200
  • TODAY'S CHANGE (%)
    Trending Down-2.8900 (-1.0947%)
  • Bid / Lots
    260.8100/ 1
  • Ask / Lots
    261.3800/ 2
  • Open / Previous Close
    260.7900 / 264.0100
  • Day Range
    Low 259.8650
    High 263.4900
  • 52 Week Range
    Low 219.8450
    High 379.2950
  • Volume
    20,366
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 264.01
TimeVolumeABMD
09:32 ET2045259.865
09:36 ET100261.45
09:38 ET900262.02
09:39 ET100261.41
09:41 ET100261.41
09:43 ET1346261.25
09:45 ET533260.31
09:48 ET300261.72
09:50 ET100262.14
09:54 ET400261.91
09:57 ET100261.24
09:59 ET1000263.005
10:01 ET200262.36
10:08 ET100260.765
10:12 ET216261
10:14 ET200261.34
10:15 ET669260.86
10:17 ET781260.18
10:19 ET100261.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABMD
ABIOMED Inc
11.0B
55.1x
+20.58%
United StatesOMCL
Omnicell Inc
3.8B
70.0x
+43.74%
United StatesEVH
Evolent Health Inc
3.4B
-164.9x
---
United StatesQDEL
Quidelortho Corp
4.8B
3.2x
---
United StatesITGR
Integer Holdings Corp
2.0B
29.1x
+28.34%
United StatesIRTC
iRhythm Technologies Inc
3.6B
-29.8x
---
As of 2022-10-05

Company Information

ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Contact Information

Headquarters
22 CHERRY HILL DRDANVERS, MA, United States 01923-2575
Phone
978-777-5410
Fax
978-777-8411

Executives

Chairman of the Board, President, Chief Executive Officer
Michael Minogue
Chief Financial Officer, Executive Vice President
Todd Trapp
Executive Vice President, General Counsel, Company Secretary
Marc Began
Executive Vice President, Chief Commercial Officer
Andrew Greenfield
Lead Independent Director
Dorothy Puhy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.0B
Revenue (TTM)
$1.1B
Shares Outstanding
45.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.35
EPS
$4.74
Book Value
$33.01
P/E Ratio
55.1x
Price/Sales (TTM)
10.4
Price/Cash Flow (TTM)
44.9x
Operating Margin
24.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.